The latest health news
In 2016, a landmark report was issued on the global problem of antimicrobial resistance. The paper, commissioned by the U.K. government and the Wellcome Trust, sought to quickly grab the …
Read More
Following the Food and Drug Administration’s recent decision to give the green light to aducanumab, the first treatment approved for Alzheimer’s disease in nearly two decades, the agency has been …
Read More
Editor’s note: A recording of the event is embedded below. As the biotechnology industry holds its biggest conference, BIO Digital 2021, STAT brings you a look at how Covid-19 has …
Read More
This week’s “First Opinion Podcast” is a special two-part episode focusing on the controversial — some say inflammatory — FDA decision to approve aducanumab, an Alzheimer’s drug developed by Biogen …
Read More
Harry Johns is ready to stop talking about whether or not the Food and Drug Administration should have approved Aduhelm, the divisive new Alzheimer’s treatment that got the green light …
Read More
Like many people, I was shocked when the Food and Drug Administration ignored the advice of its neurological drugs advisory panel and broadly approved Biogen’s new drug, Aduhelm, even for …
Read More
People living with Alzheimer’s dementia — the forgetfulness, the confusion, and the ultimate erasure of identity — and their families pushed hard for the Food and Drug Administration to approve …
Read More
When Eli Lilly announced in 2017 that it would stop producing quinidine, it was the only medication approved for severe malaria treatment in the U.S. As quinidine supplies dwindled, the …
Read More
Editor’s note: A recording of the event is embedded below. After the biggest meeting in cancer research, sit down with cancer’s biggest decision-maker: the director of the Food and Drug …
Read More